That was on the 70's and today's communication/logistics tech are heaps better so it would be quicker. Again, depends on the sourcing of the required machine parts plus how relentless the full Puna/Argosy team is working on rectifying the filtration issues. I am sure they are. But there will always be birth pains and Puna is no exception. And those that are still to construct their plants like GLN, Rio Tinto ( who has not had their EIA for the 3ktpa plant yet) Posco, LKE and some others would experience the same IMO. At the very least, Puna /AGY already has proven it's chemical process to produce battery grade. And we need to consider that there will be maintenance stoppages in the future too.
in any case, it is not a bad thing for AGY to report on the problem even if it has not fully rectified the works. For me, it is enough to know that the team is working on the rectification and the problem can be fixed. Hopefully, it is very soon so we can move on.
- Forums
- ASX - By Stock
- AGY
- General Discussion AGY
General Discussion AGY, page-18945
-
- There are more pages in this discussion • 4,312 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGY (ASX) to my watchlist
|
|||||
Last
8.5¢ |
Change
-0.008(8.60%) |
Mkt cap ! $123.7M |
Open | High | Low | Value | Volume |
9.0¢ | 9.3¢ | 8.5¢ | $362.9K | 4.093M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 8.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.7¢ | 93664 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 459867 | 0.085 |
3 | 99873 | 0.084 |
4 | 169062 | 0.083 |
3 | 336585 | 0.082 |
2 | 114691 | 0.081 |
Price($) | Vol. | No. |
---|---|---|
0.087 | 93664 | 1 |
0.088 | 232558 | 1 |
0.089 | 69615 | 2 |
0.090 | 91167 | 2 |
0.091 | 52101 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online